|HB4900 Engrossed||LRB100 20493 MJP 35855 b|
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
This Act may be cited as the
Illinois Generic Drug Pricing Fairness Act.
As used in this Act:
"Essential off-patent or generic drug" means any
prescription drug sold within the State:
(1) for which all exclusive marketing rights, if any,
granted under the Federal Food, Drug, and Cosmetic Act,
Section 351 of the federal Public Health Service Act, and
federal patent law have expired;
(2) that appears on the model list of essential
medicines most recently adopted by the World Health
Organization or that has been designated by the United
States Secretary of Health and Human Services as an
essential medicine due to its efficacy in treating a
life-threatening health condition or a chronic health
condition that substantially impairs an individual's
ability to engage in activities of daily living; and
(3) that is actively manufactured and marketed for sale
in the United States by 3 or fewer manufacturers.
"Essential off-patent or generic drug" includes any